Publications by the researcher in collaboration with Marc Miravitlles (12)

2023

  1. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  2. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  3. Exacerbations in COPD: a personalised approach to care

    The Lancet Respiratory Medicine

  4. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  5. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

    Biomedicines, Vol. 11, Núm. 2

  6. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  2. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

2021

  1. Utility of transient elastography for the screening of liver disease in patients with alpha1-antitrypsin deficiency

    Journal of Clinical Medicine, Vol. 10, Núm. 8

2018

  1. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions

    Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1

2017

  1. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease

    Journal of the American Medical Directors Association, Vol. 18, Núm. 12, pp. 1097.e11-1097.e24

2014

  1. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems

    Health and Quality of Life Outcomes, Vol. 12, Núm. 1